Variable | Constrictor | Intermediate | Sustainer | p-value |
---|---|---|---|---|
Number of subjects | 109 | 139 | 222 | |
Age (years) | 46 (37–53) | 46 (38–57) | 47 (38–55) | 0.216 |
Female (%) | 80 | 58* | 32*† | <0.001 |
BP ≥ 135/85 mmHg (%) in the laboratory | 34 | 42* | 51*† | 0.009 |
Body mass index (kg/m2) | 23.1 (21.6–25.6) | 26.5 (24.1–29.3)* | 27.4 (24.8–30.6)* | <0.001 |
Waist circumference (cm) | ||||
Female | 79 (73–87) | 86 (79–97)* | 88 (82–99)* | <0.001 |
Male | 85 (80–92) | 98 (91–99)* | 100 (94–107)* | <0.001 |
Smoking (no/present/previous) | 66/16/27 | 90/14/35 | 121/23/78 | 0.090 |
Office systolic BP (mmHg) | 134 (119–148) | 139 (123–152) | 141 (123–157)* | 0.007 |
Office diastolic BP (mmHg) | 84 (75–91) | 90 (81–98)* | 91 (82–99)* | <0.001 |
Haematocrit | 0.40 (0.39–0.42) | 0.42 (0.39–0.44)* | 0.43 (0.41–0.45)*† | <0.001 |
Creatinine (μmol/l) | 66 (59–74) | 70 (64–80)* | 76 (69–84)*† | <0.001 |
eGFR (ml/min/1.73 m2) | 89 (80–97) | 88 (79–97) | 89 (78–99) | 0.631 |
Total Cholesterol (mmol/l) | 4.80 (4.20–5.50) | 5.20 (4.60–5.80)* | 5.20 (4.4–5.8)* | 0.018 |
LDL Cholesterol (mmol/l) | 2.45 (2.10–3.18) | 3.00 (2.40–3.60)* | 3.10 (2.30–3.70)* | <0.001 |
HDL cholesterol (mmol/l | 1.78 (1.49–2.13) | 1.54 (1.23–1.84)* | 1.43 (1.17–1.71)* | <0.001 |
Triglycerides (mmol/l) | 0.92 (0.61–1.16) | 1.08 (0.82–1.43)* | 1.11 (0.76–1.67)*† | <0.001 |
Fasting plasma glucose (mmol/l) | 5.2 (4.9–5.4) | 5.4 (5.1–5.7)* | 5.5 (5.1–5.8)* | <0.001 |